A study of assessing knowledge, attitude and practice of pharmacovigilance among medical students of a South Indian teaching hospital

Kulkarni Dhananjay, Esanakula Himasri


Background: Pharmacovigilance is the science relating to detection, assessment, understanding and prevention of adverse drug reaction. The purpose is to improve patient safety in relation to use of medicines. It is estimated that only 6-10% of adverse drug reactions (ADRs) are reported worldwide. The underreporting of ADR is due to lack of adequate knowledge, attitude and practice among healthcare professionals towards ADR reporting. Health care professional like physicians, pharmacist and nurses have immense responsibility in reporting ADR. Therefore, the objective of this study was to evaluate the knowledge, attitude and practices (KAP) of undergraduate medical students towards pharmacovigilance.

Methods: A cross-sectional KAP based questionnaires study was carried out in 100 undergraduate students of Konaseema Institute of Medical Sciences, Amalapuram. The response of KAP questionnaires were analyzed in percentage and tabular form.

Results: Nearly 87% participants heard about pharmacovigilance, but only 65% know its need or purpose. 88% people feel that ADR reporting may improve patient safety. Less than half of the students know about Institutional ADR centre. 81% students have seen ADR but only 31% knew about ADR reporting form and surprisingly only 20% have reported ADR. More than 80% feels reporting ADR will increase patient safety.

Conclusions: Participants have good knowledge about Pharmacovigilance but lacks in attitude and practice towards reporting ADR. Greater awareness of pharmacovigilance and incorporation of it in medical curriculum will further strengthen pharmacovigilance activity.


Adverse drug reaction (ADR), Drug safety, Knowledge Attitude practice (KAP), Pharmacovigilance

Full Text:



The Importance of Pharmacovigilance; Safety monitoring of medicinal products. WHO information booklet: 2002. Available at

Handbook of resolutions and decisions of the World Health Assembly and Executive Board. 1972;11948. Geneva: World Health Organization, 1973. WHA16.36 Clinical and pharmacological Evaluation of Drugs.

Moore N. The role of the clinical pharmacologist in the management of ADRs. Drug Safety. 2001;24(1):1-7.

Bapna JS, Tripathi CD, Tekur U. Drug utilization patterns in the third world. Pharmacoeconomics. 1996;9(4):286-94.

Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected adverse drug reactions, Arch Intern Med. 2005;165:1363-9.

Ratan JL, Mangala L. An update on the Pharmacovigilance Programme of India. Front Pharmacol. 2015;6:194. Available at

Drug Benefits and Risks - International Textbook of Clinical Pharmacology (2nd edition). Van Boxtel C, Santoso B and Edwards IR, eds. IOS Press, Amsterdam, 2008.

Vigibase LM. The WHO Global ICSR Database System: Basic Facts. Drug Information Journal. 2008;42:409-19.

Vallano A, Cereza G, Pedros C, Agusti A, Danes I, Aguilera C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-8.

Desai CK, Iyer PG, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction among prescriber at a tertiary care hospital. Perspect Clin Res. 2011;2(4):129-36.

Rajesh R, Vidyasagar S, Varma DM. An educational intervention to assess knowledge, Attitude, practice of spharmacovigilance among healthcare professional in an Indian tertiary care teaching hospital. Int J Pharm Tech Res. 2011;3(2):678-92.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Nat Sci Biol Med. 2013;4(1):191-6.

Alan S, Ozturk M, Gokyildiz S, Avcibay B, Karatas Y, An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey. Indian J Pharmacol. 2013;45(6):616-8.

Fadare J, Enwere O, Afolabi AO, Chedi BAZ, Musa A. Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in northern Nigeria. Trop J Pharm Res. 2011;10(3):235-42.

Gupta P, Udupa A. Adverse drug reporting and pharmacovigilance: Knowledge, attitude and perception among resident doctors. J Pharm Sci Res. 2011;3:1064-6.

Palaian S, Ibrahim MI, Mishra P. Health professionals’ knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract (Granada) 2011;9:228-35.

Meher BR, Joshua N, Asha B, Mukherji D. A questionnaire based study to assess knowledge, attitude and practice of pharmacovigilance among undergraduate medical students in a Tertiary Care Teaching Hospital of South India. Perspect Clin Res. 2015;6:217-21.

Parthiban G, Nileshraj G, Mangaiarkkarasi A, Meher Ali R. A survey on knowledge, attitude and awareness of pharma covigilance among medical students in a teaching hospital, Puducherry. Indian Journal of Basic and Applied Medical Research. December 2015;5(1):198-203.

Hema NG, Bhuvana KB, Sangeetha. Pharmacovigilance: The extend of awareness among the final year students, interns and postgraduates in a government teaching hospital. J Clin Diagn Res. 2012;6(7):1248-53.

Datta S, Sengupta S. An evaluation of knowledge, attitude and practice of adverse drug reaction reporting in a tertiary care teaching hospital of Sikkim. Perspect Clin Res. 2015;6(4):200-6.

Ganesan S, Vikneswaran G, Reddy KC, Subrahmanyam DK, Adithan C. A Survey on Knowledge, Attitude and Practice of Pharmacovigilance towards Adverse drug reactions reporting among Doctors and Nurses in a Tertiary Care Hospital in South India. J Young Pharm. 2016;8(4):471-6.

Agarwal R, Daher AM, Ismail MN. Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from Klang valley in Malaysia. Malays J Med Sci. 2013;20(2):52-61.

Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero J. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825-33.

Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: Literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15(20):1-234.

Kharkar M, Bowalekar S. Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. Perspect Clin Res. 2012 Jul-Sep;3;3:90-4.

Nichols V, Thériault-Dubé I, Touzin J, Delisle JF, Lebel D, Bussières JF, et al. Risk perception and reasons for noncompliance in pharmacovigilance: a qualitative study conducted in Canadá. Drug Saf. 2009;32(7):579-90.

Gavaza P, Brown CM, Khoza S. Texas pharmacists’ opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study. Pharm World Sci. 2010;32(5):651-7.

Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J. 2004;117(6):856-61.

Pernas SIS, Herdeiro MT, Lopez-Gonzalez E, da Cruz e Silva OA, Figueiras A. Attitudes of Portuguese health professionals toward adverse drug reaction reporting. Int J Clin Pharm. 2012;34(5):693-8.